NanoValent Pharmaceuticals, Inc.
| 910 Technology BLVD STE G
Bozeman, MT, 59718-4012
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||2|
This Small Business Innovation Research Phase II project will develop targeted nanoparticle delivery systems capable of delivering conventional cytotoxics preferentially to tumor cells. While therapeu ...SBIR Phase II 2013 National Science Foundation
This Small Business Innovation Research (SBIR) Phase I project aims to explore the application of a targeted nanodelivery system for both treatment and efficacy monitoring in patients with adult leuke ...SBIR Phase I 2012 National Science Foundation